JPSP - 2022 - 236 PDF
JPSP - 2022 - 236 PDF
JPSP - 2022 - 236 PDF
com
2022, Vol. 6, No. 8, 2498-2507
ABSTRACT
Background: It is a transitional rapid growth phase of individual development between childhood and
adulthood. Adolescents feel changes in cognitive, emotional, physical, intellectual, attitudinal, social
roles, relationships, redeployment, and self-discovery during this phase, which is a stressful experience
for them. Although it is the phase of tremendous growth in preparation of adults' roles and skills to
sustain pressures and challenges, it is also a transitory phase that can raise the risk of various
psychopathology or mental health problems. Objective: The present study aims to assess the prevalence
of psychopathology among school adolescents. Methods: The sample consisted of 200 school-going
adolescents through simple random sampling from the different districts of Jharkhand. Both male and
female adolescents in the age range of 13 to 17 years were recruited for the study. Both male and female
adolescents were studying in 8th to 10th standard and had no history of mental retardation and major
physical illness. Socio-demographic and Clinical Datasheet, Informed Consent Form, and
Adolescents Psychopathology Scale (APS-SF) were used for data collection. Results & conclusion:
Overall findings of the present study indicated that moderate level prevalence rate of psychopathology
i.e. conduct disorder (5.5%), generalized anxiety disorder (5.5%), major depression (7.5%), eating
disturbance (6%), suicide (10%) and interpersonal problems (5%) have been existing among
adolescents.
Variable N Percentage
Male 95 47.5%
Gender
Female 105 52.5%
8th 46 23.0%
Class 9th 36 18.0%
10th 118 59.0%
13 Years 23 11.5%
14 Years 32 16.0%
Age 15 Years 60 30.0%
16 Years 51 25.5%
17 Years 34 17.0%
Hindu 187 93.5%
Muslim 3 1.5%
Ethnicity
Christian 4 2.0%
Others 6 3.0%
Gender
Variables Male Female χ2 p
N % N %
Normal range 77 47.8% 84 52.2%
Subclinical symptom range 9 60.0% 6 40.0%
Conduct
Mild clinical symptom range 3 33.3% 6 66.7% 5.50 0.23
Disorder (CND)
Moderate clinical symptom range 6 54.4% 5 45.5%
Severe clinical symptom range 0 0.0% 4 100.0%
Normal range 93 47.2% 104 52.8%
Oppositional Subclinical symptom range 2 100.0% 0 0.0%
Defiant Disorder Mild clinical symptom range 0 0.0% 0 0.0% 3.12 0.21
(OPD) Moderate clinical symptom range 0 0.0% 1 100.0%
Severe clinical symptom range 0 0.0% 0 0.0%
Normal range 89 46.8% 101 53.2%
Substance Subclinical symptom range 2 50.0% 2 50.0%
Abuse Disorder Mild clinical symptom range 2 100.0% 0 0.0% 2.26 0.52
(SUB) Moderate clinical symptom range 0 0.0% 0 0.0%
Severe clinical symptom range 2 50.0% 2 50.0%
Normal range 72 45.0% 88 55.0%
Anger/Violene Subclinical symptom range 9 52.9% 8 47.1%
Proneness Mild clinical symptom range 11 64.7% 6 35.3% 3.83 0.42
(AVP) Moderate clinical symptom range 3 60.0% 2 40.0%
Severe clinical symptom range 0 0.0% 1 100.0%
Academic Normal range 76 45.8% 90 54.2%
2.91 0.40
Problems (ADP) Subclinical symptom range 14 60.9% 9 39.0%
SANGITA KUMARI 2502
Class ꭕ2 p-value
th
Variables 8 9 10
N % N % N %
Normal range 3
23.6% 32 19.9% 91 56.5%
8
Conduct
Subclinical symptom range 3 20.0% 1 6.7% 11 73.3%
Disorder 5.76 0.67
Mild clinical symptom range 3 33.3% 1 11.1% 5 55.6%
(CND)
Moderate clinical symptom range 2 18.2% 2 18.2% 7 63.6%
Severe clinical symptom range 0 0.0% 0 0.0% 4 100.0%
Normal range 4
22.8% 36 18.3% 116 58.9%
Oppositionl 5
Defiant Subclinical symptom range 1 50.0% 0 0.0% 1 50.0%
1.72 0.78
Disorder Mild clinical symptom range 0 0.0% 0 0.0% 0 0.0%
(OPD) Moderate clinical symptom range 0 0.0% 0 0.0% 1 100.0%
Severe clinical symptom range 0 0.0% 0 0.0% 0 0.0%
Normal range 4
24.2% 34 17.9% 110 57.9%
6
Substance
Subclinical symptom range 0 0.0% 0 0.0% 4 100.0%
Abuse
Mild clinical symptom range 0 0.0% 1 50.0% 1 50.0% 5.76 0.45
Disorder
Moderate clinical symptom range 0 0.0% 0 0.0% 0 0.0%
(SUB)
Severe clinical symptom range 4
23.0% 36 18.0% 118 59.0%
6
Normal range 3
21.9% 32 20.0% 93 58.1%
Anger/Viol 5
ence Subclinical symptom range 6 35.3% 1 5.9% 10 58.8%
4.15 0.84
Proneness Mild clinical symptom range 4 23.5% 2 11.8% 11 64.7%
(AVP) Moderate clinical symptom range 1 20.0% 1 20.0% 3 60.0%
Severe clinical symptom range 0 0.0% 0 0.0% 1 100.0%
Normal range 3
22.3% 35 21.1% 94 56.6%
7
Academic
Subclinical symptom range 7 30.4% 1 4.3% 15 65.2%
Problems 8.47 0.20
Mild clinical symptom range 2 28.6% 0 0.0% 5 71.4%
(ADP)
Moderate clinical symptom range 0 0.0% 0 0.0% 4 100.0%
Severe clinical symptom range 0 0.0% 0 0.0% 0 0.0%
Normal range 3
22.2% 33 20.9% 90 57.0%
Generalized 5
Anxiety Subclinical symptom range 4 23.5% 2 11.8% 11 64.7%
6.19 0.62
Disorder Mild clinical symptom range 4 33.3% 0 0.0% 8 66.7%
(GAD) Moderate clinical symptom range 3 27.3% 1 9.1% 7 63.6%
Severe clinical symptom range 0 0.0% 0 0.0% 2 100.0%
Posttraumat Normal range 3
22.4% 26 17.7% 88 59.9%
ic Stress 3
5.46 0.48
Disorder Subclinical symptom range 7 35.0% 4 20.0% 9 45.0%
(PTS) Mild clinical symptom range 6 22.2% 5 18.5% 16 59.3%
SANGITA KUMARI 2504
Absent Present
Variables Total
(%) Mild Moderate Severe
Conduct Disorder (CND) 176 (88%) 9 (4.5%) 11 (5.5%) 4 (2%) 200 (100%)
Oppositional Defiant
Disorder (OPD) 199 (99.5%) 0 (0%) 1 (0.5%) 0 (0%) 200 (100%)
Substance Abuse Disorder
(SUB) 194 (97%) 2 (1%) 0 (0%) 4 (2%) 200 (100%)
Anger/Violence Proneness
(AVP) 177 (88.5%) 17 (8.5%) 5 (2.5%) 1(0.5%) 200 (100%)
Academic Problems
(ADP) 189 (94.5%) 7 (3.5%) 4 (2%) 0 (0%) 200 (100%)
2505 Journal of Positive School Psychology
Generalized Anxiety
Disorder (GAD) 175 (87.5%) 12 (6%) 11 (5.5%) 2 (1%) 200 (100%)
Posttraumatic Stress
Disorder (PTS) 168 (84%) 27(13.5%) 0 (0%) 5 (2.5%) 200 (100%)
Major Depression (DEP) 170 (85%) 14(7%) 15 (7.5%) 1 (0.5%) 200 (100%)
Eating Disturbance(EAT) 174 (87%) 9 (4.5%) 12 (6%) 5 (2.5%) 200 (100%)
Suicide (SUI) 162 (81%) 7 (3.5%) 20 (10%) 11(5.5%) 200 (100%)